Ex­clu­sive: Cel­lares ex­pands deal with Bris­tol My­ers on CAR-T as­set, eyes man­u­fac­tur­ing ex­pan­sion

Cel­lares has ex­pand­ed its part­ner­ship deal with Bris­tol My­ers Squibb to as­sist the Big Phar­ma in de­vel­op­ing an­oth­er un­named CAR-T cell ther­a­py via its cell ther­a­py man­u­fac­tur­ing plat­form, Cell Shut­tle.

The South San Fran­cis­co com­pa­ny al­so has its eyes on long-term ex­pan­sion, which in­cludes new col­lab­o­ra­tions and new builds in US, Eu­rope and Asia, CEO Fabi­an Ger­ling­haus said. There’s been an “avalanche of in­ter­est” from phar­ma com­pa­nies look­ing to part­ner, Ger­ling­haus told End­points News in an in­ter­view.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER